Soligenix Inc — Quarterly Financial Statistics (NASDAQ:SNGX)

Financials

Cash from operating activities -2.91 M-2.23 M-1.85 M-2.74 M-2.93 M -9.75 M Cash from investing activities ————— — Cash from financing activities 3.29 M242.88 K1.32 M545.63 K8.36 M 10.47 M Free cash flow -2.91 M-2.23 M-1.85 M-2.74 M-2.93 M -9.75 M

SNGX

Financials

뉴스

솔리제닉스, 희귀 의약품 지정에 대한 EMA 긍정적 의견 접수

Soligenix receives positive EMA opinion for orphan drug status